Utilising polyphenols for the clinical management of Candida albicans biofilms
Polyphenols (PPs) are secondary metabolites abundant in plant-derived foods. They are reported to exhibit antimicrobial activity that may offer an alternative to existing antimicrobials. The aim of this study was to evaluate the antifungal potential of PPs against Candida albicans biofilms that are...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/46816 |
| _version_ | 1848757665301266432 |
|---|---|
| author | Shahzad, M. Sherry, L. Rajendran, R. Edwards, Christine Combet, E. Ramage, G. |
| author_facet | Shahzad, M. Sherry, L. Rajendran, R. Edwards, Christine Combet, E. Ramage, G. |
| author_sort | Shahzad, M. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Polyphenols (PPs) are secondary metabolites abundant in plant-derived foods. They are reported to exhibit antimicrobial activity that may offer an alternative to existing antimicrobials. The aim of this study was to evaluate the antifungal potential of PPs against Candida albicans biofilms that are commonly recalcitrant to antifungal therapy. The antifungal activity of 14 PPs was assessed in terms of planktonic and sessile minimum inhibitory concentrations (PMICs and SMICs, respectively) against various C. albicans clinical isolates. The most active PPs were further tested for their effect on C. albicans adhesion and biofilm growth using standard biomass assays, microscopy and quantitative gene expression. Of the 14 PPs tested, 7 were effective inhibitors of planktonic growth, of which pyrogallol (PYG) was the most effective (PMIC50=78 µg/mL), followed by curcumin (CUR) (PMIC50=100 µg/mL) and pyrocatechol (PMIC50=625 µg/mL). Both PYG and CUR displayed activity against C. albicans biofilms (SMIC50=40 µg/mL and 50 µg/mL, respectively), although they did not disrupt the biofilm or directly affect the cellular structure. Overall, CUR displayed superior biofilm activity, significantly inhibiting initial cell adhesion following pre-coating (P<0.01), biofilm growth (P<0.05) and gene expression (P<0.05). This inhibitory effect diminished with prolonged CUR exposure, although it still inhibited by 50% after 4h adhesion. Overall, CUR exhibited positive antibiofilm properties that could be used at the basis for development of similar molecules, although further cellular and in vivo studies are required to explore its precise mechanism of action. |
| first_indexed | 2025-11-14T09:31:42Z |
| format | Journal Article |
| id | curtin-20.500.11937-46816 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T09:31:42Z |
| publishDate | 2014 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-468162018-03-29T09:07:32Z Utilising polyphenols for the clinical management of Candida albicans biofilms Shahzad, M. Sherry, L. Rajendran, R. Edwards, Christine Combet, E. Ramage, G. Polyphenols (PPs) are secondary metabolites abundant in plant-derived foods. They are reported to exhibit antimicrobial activity that may offer an alternative to existing antimicrobials. The aim of this study was to evaluate the antifungal potential of PPs against Candida albicans biofilms that are commonly recalcitrant to antifungal therapy. The antifungal activity of 14 PPs was assessed in terms of planktonic and sessile minimum inhibitory concentrations (PMICs and SMICs, respectively) against various C. albicans clinical isolates. The most active PPs were further tested for their effect on C. albicans adhesion and biofilm growth using standard biomass assays, microscopy and quantitative gene expression. Of the 14 PPs tested, 7 were effective inhibitors of planktonic growth, of which pyrogallol (PYG) was the most effective (PMIC50=78 µg/mL), followed by curcumin (CUR) (PMIC50=100 µg/mL) and pyrocatechol (PMIC50=625 µg/mL). Both PYG and CUR displayed activity against C. albicans biofilms (SMIC50=40 µg/mL and 50 µg/mL, respectively), although they did not disrupt the biofilm or directly affect the cellular structure. Overall, CUR displayed superior biofilm activity, significantly inhibiting initial cell adhesion following pre-coating (P<0.01), biofilm growth (P<0.05) and gene expression (P<0.05). This inhibitory effect diminished with prolonged CUR exposure, although it still inhibited by 50% after 4h adhesion. Overall, CUR exhibited positive antibiofilm properties that could be used at the basis for development of similar molecules, although further cellular and in vivo studies are required to explore its precise mechanism of action. 2014 Journal Article http://hdl.handle.net/20.500.11937/46816 10.1016/j.ijantimicag.2014.05.017 restricted |
| spellingShingle | Shahzad, M. Sherry, L. Rajendran, R. Edwards, Christine Combet, E. Ramage, G. Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title | Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title_full | Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title_fullStr | Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title_full_unstemmed | Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title_short | Utilising polyphenols for the clinical management of Candida albicans biofilms |
| title_sort | utilising polyphenols for the clinical management of candida albicans biofilms |
| url | http://hdl.handle.net/20.500.11937/46816 |